phase 4
ii 2
study 2
belinostat 1
pxd 1
relapsed 2
refractory 2
aggressive 1
bcell 2
lymphomas 1
swog 2
s 2
trial 2
rchop 1
plus 1
bortezomib 2
induction 1
therapy 1
followed 1
maintenance 1
newly 1
diagnosed 1
mantle 1
cell 1
lymphoma 4
imexon 1
prooxidant 1
molecule 1
nonhodgkin 1
comparative 1
analysis 1
prognostic 1
factor 1
models 1
follicular 2
based 1
iii 1
choprituximab 1
versus 1
chop 1
iodinetositumomab 1
intratumoral 1
cdcdgitr 1
regulatory 1
t 2
cells 2
potently 1
suppress 1
cdcdcostimulated 1
autologous 1
allogeneic 1
cdcd 2
